Center for biologics evaluation and research (cber), biologics effectiveness and safety (best) initiative: development of new and innovative methods for automated reporting for cber-regulated biologic
Ended Awarded Last action
- Contract number
- 75F40122F19004
- Awardee
-
International Business Machines Corporation UEI VV9KH3L99VE3 Part of International Business Machines Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $8,234,421
Award facts
- Contract value 100% obligated
- $8,234,421.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Westlake, MD 20817, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,637 | |
| Supplemental Agreement for work within scope | $87,467 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $3,150,000 | |
| Original award | $4,999,592 |
About this award
This federal contract award was issued by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to support the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative. The $8,234,421.12 delivery order contract will develop new and innovative methods for automated reporting for CBER-regulated biologics. The contract is a Time and Materials (T&M) type and does not have a set-aside designation. IBM will be the prime contractor on this work, which has a period of performance through September 26, 2024. This contract is associated with the larger BEST Initiative program, which aims to advance the FDA's capabilities in biologic product monitoring and safety surveillance.
Quick answers
Who was awarded contract 75F40122F19004?
75F40122F19004 was awarded to International Business Machines Corporation by Food and Drug Administration (Department of Health and Human Services) on September 27, 2022.
How much is contract 75F40122F19004 worth?
The government has obligated $8,234,421 on 75F40122F19004.
Is contract 75F40122F19004 an order under another contract?
Yes. 75F40122F19004 is a delivery order under 75F40118D10053, an indefinite delivery contract, on BEST Initiative - New and Innovative Methods for Automated Reporting.
Was contract 75F40122F19004 competed?
The extent of competition for 75F40122F19004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award